This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Ramón Llull: Innovator in Adipose-Derived Stem Cell Technology
Introduction
Ramón Llull is a notable inventor based in Mallorca, Spain. He has made significant contributions to the field of regenerative medicine, particularly through his work with adipose-derived stem cells. His innovative approach has the potential to revolutionize tissue engineering and regenerative therapies.
Latest Patents
Ramón Llull holds a patent for "Adipose-derived stem cells and lattices." This invention provides adipose-derived stem cells (ADSCs), adipose-derived stem cell-enriched fractions (ADSC-EF), and adipose-derived lattices. The patent describes an ADSC that is substantially free of adipocytes and red blood cells, along with clonal populations of connective tissue stem cells. These ADSCs can be utilized to generate differentiated tissues and structures, both in vivo and in vitro. Furthermore, the invention includes an adipose-derived lattice that is substantially devoid of cells, which serves as a substrate to facilitate the growth and differentiation of cells.
Career Highlights
Throughout his career, Ramón Llull has focused on advancing the understanding and application of stem cell technology. His work has contributed to the development of biologically-compatible compositions that support the growth and expansion of various cell populations. His innovative research has positioned him as a key figure in the field of regenerative medicine.
Collaborations
Ramón has collaborated with esteemed colleagues such as Marc H Hedrick and J William Futrell. These partnerships have further enhanced the impact of his research and innovations in the field.
Conclusion
In summary, Ramón Llull is a pioneering inventor whose work with adipose-derived stem cells has the potential to transform regenerative medicine. His contributions are paving the way for new therapies and advancements in tissue engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile